Friday, November 24, 2017
  • MS & Me
  • MS Info Hub
  • MS News
  • MS Radio

Multiple Sclerosis (MS) Disease Modifying Treatments and Therapies

Overview: What are Disease Modifying Therapies? Presently no cure exists for multiple sclerosis and thus it is considered a chronic disease. Disease-modifying medications attempt to alter the course of the disease to lessen or stop disease activity and progression.  Multiple sclerosis requires a comprehensive individualized care...

Aubagio® (Teriflunomide) Multiple Sclerosis (MS) Oral Pill Disease Modifying Therapy

Aubagio® (Teriflunomide) Overview: Aubagio® (Teriflunomide) is a prescription medication approved by the Food and Drug Administration (FDA) in 2012 for treating adults with relapsing forms of multiple sclerosis (MS). It is also known by its drug name, Teriflunomide. Aubagio has been shown to reduce rates of...

Avonex (Interferon Beta 1a) Multiple Sclerosis (MS) Injectable Disease Modifying Therapy

Avonex (Interferon Beta 1a) Overview:  Avonex® (Interferon beta 1a) is a medication manufactured by a biotechnological process from one of the naturally-occurring interferons (a type of protein). It is made up of exactly the same amino acids (major components of proteins) as the interferon beta found...

Betaseron ® (Interferon Beta-1b) Multiple Sclerosis (MS) Injectable Disease Modifying Therapy Information

Betaseron ® (Interferon Beta-1b) Overview: BETASERON® (interferon beta-1b) is a prescription medicine used to reduce the number of relapses in people with relapsing forms of multiple sclerosis (MS). This includes people who have had their first symptoms of multiple sclerosis and have an MRI consistent with...

Copaxone® (Glatiramer Acetate) Multiple Sclerosis (MS) Injectable Disease Modifying Therapy

Copaxone® (Glatiramer Acetate) Overview: Copaxone® (glatiramer acetate) is a synthetic protein that simulates myelin basic protein, a component of the myelin that insulates nerve fibers in the brain and spinal cord. This drug seems to block myelin-damaging T-cells through a mechanism that is not completely understood. Glatiramer acetate...

Extavia® (Interferon Beta 1b) Multiple Sclerosis (MS) Injectable Disease Modifying Therapy

Extavia® (Interferon Beta 1b) Overview: EXTAVIA is one of several MS treatments called interferons that are known as disease-modifying therapies. Interferon beta-1b is the active ingredient in EXTAVIA and is based on a protein that's found naturally in the human body. Interferons (IFNs) are a family of naturally...

Gilenya® (Fingolimod) Multiple Sclerosis (MS) Oral Pill Disease Modifying Therapy

Gilenya® (Fingolimod) Overview: Gilenya® (fingolimod) is an oral treatment which is thought to work by retaining certain white blood cells (lymphocytes) in the lymph nodes and thus suppressing those cells from crossing the blood brain barrier. However, Gilenya's exact mechanisms of disease progression reduction are still...

Glatopa™ (Glatiramer Acetate) Multiple Sclerosis (MS) Injectable Disease Modifying Therapy

Glatopa™ (Glatiramer Acetate)  Overview: Glatopa™ (glatiramer acetate) is a synthetic protein that simulates myelin basic protein, a component of the myelin that insulates nerve fibers in the brain and spinal cord. This drug seems to block myelin-damaging T-cells through a mechanism that is not completely understood. Glatiramer acetate is...

Lemtrada™ (Alemtuzumab) Multiple Sclerosis (MS) Intravenous Infusion Disease Modifying Therapy

Lemtrada™ (alemtuzumab) Overview: Lemtrada™ (alemtuzumab) is a prescription medication approved by the Food and Drug Administration (FDA) in November 2014 for treating adults with relapsing forms of multiple sclerosis (MS). Lemtrada is a humanized monoclonal antibody directed that causes depletion of lymphocytes (white blood cells). It...

PLEGRIDY™ (Peginterferon beta-1a) Multiple Sclerosis (MS) Injectable Disease Modifying Therapy

PLEGRIDY™ (Peginterferon beta-1a) Overview: PLEGRIDY™ (peginterferon beta-1a) is an interferon for people with relapsing forms of MS. PLEGRIDY can help reduce relapses, delay the progression of physical disability, and reduce brain lesions on MRI. Plegridy is specifically indicated for relapsing forms of multiple sclerosis. Plegridy (peginterferon beta-1a) is...

Rebif™ (Interferon beta-1a) Multiple Sclerosis (MS) Injectable Disease Modifying Therapy

Rebif (Interferon beta-1a) Overview:https://youtu.be/yVBKi1VliBI REBIF® (Interferon beta-1a) is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS). It is a form of protein called beta interferon that is produced in the body. REBIF will not cure your MS but may decrease the...

Tecfidera™ (Dimethyl Fumarate) Multiple Sclerosis (MS) Oral Pill Disease Modifying Therapy

Tecfidera (Dimethyl Fumarate) Overview: Tecfidera® (Dimethyl Fumarate) is a prescription medication approved by the Food and Drug Administration (FDA) for treating adults with relapsing forms of multiple sclerosis (MS).  Approved by the Federal Drug Administration (FDA) in March 2013 he mechanism by which dimethyl fumarate exerts...